Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US researchers solidify link between contaminated heparin and ADRs

This article was originally published in Scrip

Executive Summary

Investigators from the US Centers for Disease Control and Prevention(CDC), in conjunction with academic researchers, have published evidence to support a solid link between the outbreak of allergic-type reactions witnessed late last year and recalled heparin from Baxter Healthcare, found to be contaminated with over-sulfated chondroitin sulfate (OSCS). The study was reported online ahead of publication in the December 18th issue of the New England Journal of Medicine.





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts